The Company’s Board of Directors has adopted various stock-based compensation plans, including the Amended and Restated 2023 Stock and Incentive Plan that was approved by shareholders and became effective May 13, 2026. The plans provide for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance stock units and stock awards. Pursuant to the plans, shares are reserved for future issuance by the Company upon exercise of stock options or awards of restricted stock, restricted stock units, performance stock units or stock awards granted to directors, officers and other key employees or consultants.

The table below summarizes the transactions under the Company’s active stock-based compensation plans for the six months ended June 30, 2026:


	Stock Options Outstanding			Non-vested Restricted Stock Units Outstanding			Non-vested Performance Stock Units Outstanding
(Shares in thousands)	Number of Shares	Weighted Average Exercise Price		Number of Shares	Weighted Average Grant-Date Fair Value		Number of Shares	Weighted Average Grant-Date Fair Value
Beginning balance, January 1, 2026	62	$	23.51	1,047	$	20.24	512	$	20.84
Granted	—	—		815	19.88		255	20.12
Stock options exercised	—	—		—	—		—	—
Stock awards/units vested (earned)	—	—		(401)	20.20		(7)	22.21
Forfeited/expired	(62)	23.51		(76)	19.86		(209)	21.26

Balance, June 30, 2026	—	$	—	1,385	$	20.06	551	$	19.94

Exercisable, June 30, 2026	—	$	—

Stock-based compensation expense was $7.0 million and $8.6 million during the six month periods ended June 30, 2026 and 2025, respectively. Stock-based compensation expense is recognized ratably over the requisite service period for all stock-based awards. There was no unrecognized stock-based compensation expense related to stock options at June 30, 2026. Unrecognized stock-based compensation expense related to non-vested stock awards and stock units was $25.3 million at June 30, 2026. At such date, the weighted-average period over which this unrecognized expense is expected to be recognized was 2.0 years.

There was no intrinsic value of stock options outstanding and stock options exercisable at June 30, 2026. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the period, which was $22.65 as of June 30, 2026, and the exercise price multiplied by the number of options outstanding. There was no intrinsic value of stock options exercised during the six months ended June 30, 2026 and 2025.

The fair value of the Company’s employee stock options granted is estimated on the date of grant using the Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, changes to which can materially affect the fair value estimate. There were no stock options granted during the six months ended June 30, 2026 and 2025.